Browsing Tag
OncoSil Medical Ltd
1 post
OncoSil Medical (OSL:ASX) has pancreatic cancer data momentum, but investors now need adoption proof
OSL has TRIPP-FFX data, TGA approval and FDA pathway momentum. The bigger test is whether OncoSil can turn evidence into adoption.